IRIS
SORRENTINO, Dario Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.133
EU - Europa 2.276
AS - Asia 1.088
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 8
Totale 12.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.086
UA - Ucraina 768
CN - Cina 465
DE - Germania 459
SG - Singapore 449
FI - Finlandia 298
SE - Svezia 183
RU - Federazione Russa 164
IE - Irlanda 141
IT - Italia 126
TR - Turchia 87
BR - Brasile 45
CA - Canada 41
GB - Regno Unito 41
VN - Vietnam 37
FR - Francia 30
NL - Olanda 25
IN - India 18
IR - Iran 14
BE - Belgio 13
EU - Europa 10
PL - Polonia 8
AT - Austria 7
MX - Messico 5
CH - Svizzera 4
HK - Hong Kong 4
CZ - Repubblica Ceca 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
IL - Israele 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
PT - Portogallo 2
AZ - Azerbaigian 1
BW - Botswana 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
KR - Corea 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TW - Taiwan 1
Totale 12.563
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.394
Fairfield 1.206
Houston 818
Ann Arbor 640
Ashburn 551
Seattle 505
Jacksonville 499
Chandler 496
Wilmington 467
Dearborn 417
Cambridge 406
Singapore 307
Boardman 186
Beijing 161
Princeton 146
Munich 145
Dublin 140
Helsinki 96
Izmir 85
San Diego 69
Roanoke 61
Udine 54
Des Moines 43
Nanjing 39
Hefei 37
Dong Ket 36
Kunming 30
Ottawa 29
Norwalk 28
Ogden 28
Jinan 24
Guangzhou 19
New York 16
Nanchang 15
Redmond 15
Torre Del Greco 13
Andover 12
Brussels 12
Falls Church 12
Grafing 11
Toronto 10
Redwood City 9
Warsaw 8
Fuzhou 7
Rosendaal 7
Simi Valley 7
Changsha 6
Monmouth Junction 6
Moscow 6
Quzhou 6
Shenyang 6
Shenzhen 6
Washington 6
Chengdu 5
Hebei 5
Jyväskylä 5
Leawood 5
Los Angeles 5
Maserada Sul Piave 5
Ningbo 5
Phoenix 5
Wuhan 5
Zhengzhou 5
Agugliano 4
Baotou 4
Chongqing 4
Dallas 4
Hong Kong 4
Milan 4
Nuremberg 4
San Mateo 4
Shanghai 4
Trieste 4
Wenzhou 4
Xi'an 4
Augusta 3
Belo Horizonte 3
Council Bluffs 3
Fremont 3
Kish 3
Mumbai 3
Rio de Janeiro 3
Sacramento 3
Taizhou 3
Vienna 3
Zurich 3
Bishkek 2
Brno 2
Dalian 2
Foshan 2
Hadera 2
Hangzhou 2
Huzhou 2
Hyderabad 2
Imperia 2
Istanbul 2
Jinhua 2
Lisbon 2
London 2
Mexico 2
Totale 9.517
Salva come PNG Salva come JPEG
Nome #
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 254
Mechanisms of cellular uptake of free fatty acids 219
Cavernous transformation of the portal vein associated to multiorgan developmental abnormalities 177
Letter: when to withhold anti-TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out 165
Postoperative recurrence of Crohn's disease: the beginning of the end? 142
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 139
Functional and morphological features of isolated hepatocytes preserved in University of Wisconsin solution. 139
"Albumin Receptor" uptake kinetics do not require an intact lobular architecture and are not specific for albumin 137
Bringing Top-End Endoscopy to Regional Australia: Hurdles and Benefits 137
Hepatocellular fatty acid uptake is mediated by a plasma membrane fatty acid binding protein closely related to mitochondrial glutamic oxaloacetic transaminase. 136
Prevention of postoperative recurrence of Crohn's disease: does the type of surgery matter? 134
Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record? 131
Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet 130
Low dose infliximab for prevention of postoperative recurrence of crohn's disease: Long term follow-up and impact of infliximab trough levels and antibodies to infliximab 130
Anti-TNF's for Postoperative Recurrence in Crohn's Disease: The If's and How's 129
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus 128
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease 128
Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort 127
Hepatocellular 22Na+ uptake: effect-of-oleate 125
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 125
Acute severe colitis: infliximab and/or cyclosporine? 124
At physiologic albumin:oleate concentrations oleate uptake by isolated hepatocytes, adipocytes and cardiac myocytes is a saturable function of unbound oleate concentrations. Uptake kinetics are consistent with the conventional theory 123
Uptake of oleate by isolated rat adipocytes is mediated by a 40 kDa plasma membrane fatty acid binding protein closely related to that in liver and gut 123
The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver 121
Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate 121
Ustekinumab as induction and maintenance therapy for ulcerative colitis 121
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 120
Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related 120
Transferrin metabolism in alcoholic liver disease. 119
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 118
Mechanistic aspects of hepatic bilirubin uptake 116
Infliximab in Crohn's disease: a look at the (not so distant) future. 115
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease 114
Fibrocytes, Inflammation, and Fibrosis in Crohn's Disease: Another Piece of the Puzzle. 113
Surgery for Crohn's disease and anti-TNF agents. The changing scenario 113
Sex differences in hepatic fatty acid uptake reflect a greater affinity of the transport system in females 113
Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across? 113
Isolated Bilateral Gastrocnemius Myositis in Crohn Disease Successfully Treated with Adalimumab 113
Bile acid secretion and pool size during phenobarbital-induced hypercholeresis 112
Diagnosis and assessment of Crohn's disease: the present and the future 112
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 112
Hepatic disposition of clinically useful 5-nitrofurans 112
Transmembrane TNF-α density, but not soluble TNF-α level, is associated with primary response to infliximab in inflammatory bowel disease 112
An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients 112
Ustekinumab as induction and maintenance therapy for Crohn's disease 111
Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease 110
Prevention of postoperative recurrence of Crohn's disease by infliximab 110
Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins in liver and gut 109
Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration 109
Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? 108
Phenobarbital specifically increases the hepatocellular uptake of sulfobromophthalein-glutathione. 107
Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes 106
The hepatocellular uptake of free fatty acids is selectively preserved during starvation 105
The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease. 105
Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43 kDa plasma membrane fatty acid binding protein 102
The race for mainstream gastrointestinal endoscopy: frontrunners. 102
Familial hyperbilirubinaemia syndromes: kinetic approaches 102
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents 102
Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. 102
Quantitation of plasma membrane fatty acid binding protein by enzyme dilution and monoclonal antibody based immunoassay 100
"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy 100
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 99
Esophageal ulceration due to alendronate 99
Organic anion-transporting polypeptides: expression cloning and functional tests 99
Scientific publications in gastroenterology and hepatology in Western Europe, USA and Japan in the years 1992-1996: a global survey 99
Microbial dysbiosis in spouses of ulcerative colitis patients: Any clues to disease pathogenesis? 98
Small Bowel Inflammation in Crohn's Disease and Other Conditions 98
Heart-touching Chilaiditi's syndrome 97
Unexplained Symptoms and Hidden Inflammation in Patients With Crohn's Disease 97
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. 95
Oleate uptake kinetics in the perfused rat liver are consistent with pseudofacilitation by albumin 94
Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn's Disease 94
Clinically Significant Small Bowel Crohn's Disease Might Only be Detected by Capsule Endoscopy 94
Continuous monitoring of the biliary excretion of a pulse of labeled compounds 93
B-cell clonality in gastric mucosa of patients with Sjögren's syndrome and connective tissue diseases: relationship with Helicobacter pylori, EBV and human herpesvirus-6 (HHV-6) infections. 93
Utility of fecal markers to diagnose and monitor inflammatory bowel diseases 93
Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale 92
Helicobacter pylori infection and autoimmune processes: an emerging field of study. 91
Characterization of prelymphomatous stages of lymphoproliferation in Sjögren’s syndrome. 91
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. 90
Internet use among inflammatory bowel disease patients: an Italian multicenter survey. 90
Gastric B-cell clonal expansion and hepatitis C virus infection: a study in patients with Sjögren’s syndrome. 89
Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold? 89
Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: Kinetic evidence for a high affinity/low capacity sinusoidal membrane system 89
MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum 86
Long-term prevention of postoperative Crohn's disease recurrence with azathioprine: the wolf in the sheep clothing. 86
The hepatocellular uptake of bilirubin: current concepts and controversies. 84
The Coming of Age of Inflammatory Bowel Diseases in Asia 84
B-CELL CLONAL EXPANSION IN GASTRIC BIOPSIES OF PATIENTS WITH DYSPEPSIA AND AUTOIMMUNE-DISEASES - EFFECT OF HELICOBACTER-PYLORI ERADICATION 83
Medical prevention of postoperative recurrence of Crohn’s Disease: The state of the art 80
Hepatitis C virus infection and gastric lymphoproliferation in patients with Sjögren's syndrome 79
Risk of combining immunosuppressive and biological treatments in inflammatory bowel disease 79
Gastric lymphoid follicles: prevalence in patients with dyspepsia and with autoimmune diseases and relationship with Helicobacter pylori infection. Gastroenterology 78
235) La terapia con Infliximab più Metotrexate a basse dosi nella prevenzione delle recidive post-chirurgiche del Morbo diCrohn 78
Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study 78
Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science 78
From albumin to the cytoplasm: the hepatic uptake of organic anions 77
Management of post-operative Crohn’s disease in 2017: where do we go from here? 76
Knowledge Gaps in the Management of Postoperative Crohn’s Disease: A US National Survey 75
Therapeutic Drug Monitoring and Clinical Outcomes in Immune Mediated Diseases: The Missing Link 73
Totale 10.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020838 0 0 0 0 0 0 0 0 284 258 79 217
2020/20211.853 38 247 153 213 67 208 93 206 229 68 204 127
2021/20221.177 49 120 51 85 35 57 73 62 12 201 216 216
2022/20231.193 165 79 14 136 116 368 10 69 163 13 20 40
2023/2024276 51 29 12 2 50 50 4 21 38 2 7 10
2024/20251.203 29 171 81 38 211 183 199 192 99 0 0 0
Totale 12.959